Mikołaj Żmudziński

MŻ

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Wrocław University of Science and Technology(Current)

AGH University of Krakow

German Center for Infection Research

The University of Texas at San Antonio Health Science Center

University of Lübeck

Mikołaj Żmudziński is an author at Wrocław University of Science and Technology specializing in sars-cov-2 infection, molecular virology, and viral proteases.

ORCID

Publications per year

2020–2023

Publications

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design

Wioletta Rut, Zongyang Lv, Mikołaj Żmudziński et al. · Science Advances · 2020 · 483 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +14

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

Wioletta Rut, Katarzyna Groborz, Linlin Zhang et al. · Nature Chemical Biology · 2020 · 328 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

SARS-CoV-2 M<sup>pro</sup> Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals

Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu et al. · ACS Central Science · 2023 · 60 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +17

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase

Mikołaj Żmudziński, Wioletta Rut, Kamila Olech et al. · Scientific Reports · 2023 · 43 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study

Izabela Nawrot-Hadzik, Mikołaj Żmudziński, Adam Matkowski et al. · Pharmaceuticals · 2021 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 9